Ebola vaccine booster trial for At-Risk workers canceled before start
NCT ID NCT05959421
First seen Jun 11, 2026 · Last updated Jun 13, 2026 · Updated 1 time
Summary
This study aimed to check how long the Ebola vaccine (VSV-EBOV) protects people at risk of exposure, like lab workers or healthcare staff. It also planned to test if a booster shot strengthens immunity. The trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bernhard Nocht Centre for Clinical Trials (BNCCT)
Hamburg, 20359, Germany
-
University Hospital Frankfurt (KGU)
Frankfurt, 60590, Germany
Conditions
Explore the condition pages connected to this study.